Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Dueling Obamacare plans set to fail as deadline...
Trump declares support for Cabinet official after report...
Kristi Noem faces first major Homeland Security grilling...
GOP accuses Democrats of manufacturing affordability crisis as...
DAVID MARCUS: Minnesota’s botched legal weed rollout reeks...
Trump presses Thune to ‘get something done’ on...
Senate Dems block Republicans’ HSA plan as Obamacare...
Dem rep opens House hearing by telling Noem...
23 Dems join House Republicans to kill progressive’s...
Senate Dems’ Obamacare fix fails as Senate looks...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Investing

Nova Announces Closing of US$3.3m NASDAQ IPO

by admin July 26, 2024
July 26, 2024
Nova Announces Closing of US$3.3m NASDAQ IPO

Nova Minerals Limited (Nova or the Company) (ASX: NVA, NASDAQ: NVA, NVAWW OTC: NVAAF, FSE: QM3) is pleased to announce the closing of its underwritten US NASDAQ public offering today of 475,000 units, with each unit consisting of one American Depositary Share representing ordinary shares (“ADS”) and one warrant, with an ADS-to-ordinary-share ratio of 1 to 60, at a price to the public of US$6.92 per unit, for gross proceeds of approximately US$3.3m (AUD$4.9m) before deducting underwriting discounts and offering expenses.

Each whole warrant is exercisable for one ADS at an exercise price of US$7.266 per ADS, and will be immediately exercisable upon issuance for a period of five years following the date of issuance. In addition, Nova has granted the underwriters an option to purchase up to an additional 47,500 ADSs and/or an additional 47,500 warrants to cover over-allotments, if any until August 29, 2024.

The offering also included the purchase by the underwriters of 47,500 warrants in connection with the partial exercise by the underwriters of their over-allotment option.

The Company has issued a total of 28,500,000 ordinary fully paid shares to the depositary agent which will underlie the ADS.

The ADSs and warrants began trading on the Nasdaq Capital Market on July 24, 2024 under the symbols “NVA” and “NVAWW”, respectively.

Nova will also issue options (warrants) to the underwriters of the offer, as approved by shareholders at the general meeting held on 31 May 2024.

The Company intends to use the proceeds for resource and exploration field programs, feasibility studies, and general working capital.ThinkEquity is acting as sole book-running manager for the offering.

A registration statement on Form F-1 (File No. 333-278695) relating to the public offering was filed with the Securities and Exchange Commission (“SEC”) and became effective on July 23, 2024. This offering is being made only by means of a prospectus. Copies of the final prospectus may be obtained from ThinkEquity, 17 State Street, 41st Floor, New York, New York 10004.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Nova CEO, Mr Christopher Gerteisen commented: “This marks a major milestone for the company and highlights the quality of our team who made it happen through countless hours of dedication and hard work. A US listing has been our goal for a long time as the logical next step with our flagship Estelle Gold Project being a North American asset and an increasing US investor base. Now it’s a reality, and we believe this can be a catalyst to create further shareholder value through increased exposure and liquidity available in the US market. The company is preparing a targeted drill program to commence shortly and continues with the critical technical studies required for the completion of a robust PFS as we progress along the path to production.”

Click here for the full ASX Release

This post appeared first on investingnews.com

previous post
Melodiol Global Health
next post
Radiopharm Theranostics Targets Nasdaq Listing by End of 2024

You may also like

Havilah Deals Uranium Assets for Equity Interest in...

October 21, 2024

Skyharbour Intersects High-Grade Uranium in Significant 42 m...

June 10, 2025

Equity Metals

July 1, 2025

Perpetua’s Stibnite Gold-Antimony Project Gets Green Light for...

September 22, 2025

1911 Gold Temporarily Suspends Operations at True North...

May 31, 2025

Cyclopharm Signs US Agreement with HCA Healthcare for...

January 23, 2025

LaFleur Minerals Provides Update on PEA for the...

October 6, 2025

ELEMENT79 Announces Revocation of MCTO

March 7, 2025

What are Dividend Stocks?

January 17, 2025

Top 10 Manganese-producing Countries (Updated 2024)

July 30, 2024

Recent Posts

  • Dueling Obamacare plans set to fail as deadline nears, pushing Senate toward bipartisan talks
  • Trump declares support for Cabinet official after report he is considering replacement
  • Kristi Noem faces first major Homeland Security grilling as lawmakers press her on terror threats
  • GOP accuses Democrats of manufacturing affordability crisis as Obamacare subsidy fight nears deadline
  • DAVID MARCUS: Minnesota’s botched legal weed rollout reeks of DEI, corruption and Tim Walz

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (963)
    • Investing (3,638)
    • Politics (4,397)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 Sightful Invest. All Rights Reserved.